Carrie A Thompson

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi Care of the adult Hodgkin lymphoma survivor
    Carrie A Thompson
    Division of Hematology, Mayo Clinic College of Medicine, Department of Internal Medicine, Rochester, MN 55905, USA
    Am J Med 124:1106-12. 2011
  2. ncbi Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience
    Carrie A Thompson
    Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Br J Haematol 135:405-7. 2006
  3. ncbi Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors
    C A Thompson
    Mayo Clinic, Department of Internal Medicine, Division of Hematology, Rochester, MN 55905, USA
    Ann Oncol 21:2262-6. 2010
  4. ncbi Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients
    Carrie A Thompson
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Hematol 85:171-3. 2010
  5. ncbi Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma
    Carrie A Thompson
    Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Hematol 86:998-1000. 2011
  6. ncbi The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
    Jennifer L Kelly
    School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA
    Ann Epidemiol 22:855-62. 2012
  7. ncbi Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
    Thomas E Witzig
    Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN, USA
    Blood 118:4882-9. 2011
  8. ncbi The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
    Kathleen J Yost
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Leuk Lymphoma 54:290-7. 2013
  9. ncbi Acute renal infarction due to fungal vascular invasion in disseminated candidiasis
    Shawn M McGee
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 73:535-7. 2009
  10. ncbi Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
    Stephen M Ansell
    Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 85:824-33. 2010

Detail Information

Publications17

  1. ncbi Care of the adult Hodgkin lymphoma survivor
    Carrie A Thompson
    Division of Hematology, Mayo Clinic College of Medicine, Department of Internal Medicine, Rochester, MN 55905, USA
    Am J Med 124:1106-12. 2011
    ..This review summarizes these unique potential medical and psychologic sequelae of Hodgkin lymphoma, and provides screening and management recommendations...
  2. ncbi Pure red cell aplasia associated with thymoma: clinical insights from a 50-year single-institution experience
    Carrie A Thompson
    Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Br J Haematol 135:405-7. 2006
    ..However, treatment-related morbidity was high, with frequent infectious complications...
  3. ncbi Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivors
    C A Thompson
    Mayo Clinic, Department of Internal Medicine, Division of Hematology, Rochester, MN 55905, USA
    Ann Oncol 21:2262-6. 2010
    ..We aimed to assess anxiety and the psychological impact of routine surveillance scans in long-term survivors of adult aggressive lymphoma...
  4. ncbi Systemic AL amyloidosis with acquired factor X deficiency: A study of perioperative bleeding risk and treatment outcomes in 60 patients
    Carrie A Thompson
    Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Am J Hematol 85:171-3. 2010
    ..Optimal management of AL patients with FX deficiency undergoing invasive procedures remains to be determined...
  5. ncbi Elevated serum free light chains are associated with inferior event free and overall survival in Hodgkin lymphoma
    Carrie A Thompson
    Division of Hematology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Hematol 86:998-1000. 2011
    ..84; 95% CI: 1.84-12.7) and OS (HR = 8.87; 95% CI: 2.35-33.52) compared to patients with normal FLC. Further studies of FLC in HL are warranted...
  6. ncbi The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender
    Jennifer L Kelly
    School of Medicine and Dentistry, University of Rochester, Rochester, NY, USA
    Ann Epidemiol 22:855-62. 2012
    ..To evaluate the association of body mass index (BMI) and physical activity (PA) during adulthood and at the age of 18 years with risk of non-Hodgkin lymphoma (NHL)...
  7. ncbi Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas
    Thomas E Witzig
    Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN, USA
    Blood 118:4882-9. 2011
    ..In view of its excellent toxicity profile and novel mechanism of action, further studies in combination with other agents appear warranted. This trial is registered at www.clinicaltrials.gov as #NCT00082888...
  8. ncbi The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma
    Kathleen J Yost
    Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA
    Leuk Lymphoma 54:290-7. 2013
    ..Overall, the FACT-G was a valid measure for monitoring QoL over time in patients with NHL. However, sensitivity analyses based on subscale scoring that excludes potentially problematic items may be warranted...
  9. ncbi Acute renal infarction due to fungal vascular invasion in disseminated candidiasis
    Shawn M McGee
    Department of Urology, Mayo Medical School and Mayo Clinic, Rochester, Minnesota 55905, USA
    Urology 73:535-7. 2009
    ..Histopathologic examination of the nephrectomy specimen revealed complete infarction of the kidney secondary to Candida spp. infiltrating the parenchyma and occluding the hilar vessels...
  10. ncbi Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines
    Stephen M Ansell
    Division of Hematology, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 85:824-33. 2010
    ..Autologous stem cell transplant should be considered in all eligible patients with relapsed disease...
  11. ncbi Fibrin d-dimer concentration, deep vein thrombosis symptom duration, and venous thrombus volume
    Andrew K Kurklinsky
    Division of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Angiology 62:253-6. 2011
    ..To determine the relationship between fibrin D-dimer levels, symptom duration, and thrombus volume, consecutive patients with incident deep venous thrombosis (DVT) were evaluated...
  12. ncbi Complementary and alternative medicine use among long-term lymphoma survivors: a pilot study
    Thomas M Habermann
    Division of Hematology, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Am J Hematol 84:795-8. 2009
    ..The use of potential agents of risk by the survivors and the lack of access to potentially beneficial modalities highlights the need for further study of CAM in this population...
  13. ncbi Food-frequency questionnaire-based estimates of total antioxidant capacity and risk of non-Hodgkin lymphoma
    Shernan G Holtan
    Division of Hematology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Int J Cancer 131:1158-68. 2012
    ....
  14. ncbi Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
    Tait D Shanafelt
    Mayo Clinic, Rochester, Minnesota 55902, USA
    Cancer 118:1827-37. 2012
    ....
  15. ncbi Elevated serum free light chains are associated with event-free and overall survival in two independent cohorts of patients with diffuse large B-cell lymphoma
    Matthew J Maurer
    Mayo Clinic College of Medicine and Mayo Foundation, Rochester, MN 55905, USA
    J Clin Oncol 29:1620-6. 2011
    ..This assay has prognostic value in plasma cell proliferative disorders. There are limited data on serum FLC in B-cell malignancies...
  16. ncbi Antioxidant intake from fruits, vegetables and other sources and risk of non-Hodgkin's lymphoma: the Iowa Women's Health Study
    Carrie A Thompson
    Department of Medicine, College of Medicine Mayo Clinic, Rochester, MN, USA
    Int J Cancer 126:992-1003. 2010
    ..In conclusion, these results support a role for vegetables, and perhaps fruits and associated antioxidants from food sources, as protective factors against the development of NHL and follicular lymphoma in particular...
  17. ncbi Pure red cell aplasia and thymoma
    Carrie A Thompson
    J Thorac Oncol 2:263-4. 2007